In treatment
A blood cancer or blood disorder diagnosis can bring forth a range of emotions and questions.
We have compiled information so you can be more informed on what your condition entails and be prepared for your upcoming appointments and conversations.
Need help?
Navigating blood cancer
Blood cancer treatment options
Information about stem cell transplants, chemotherapy, radiotherapy, immunotherapy, targeted therapy, CAR T-cell therapy, clinical trials and supportive care.
Optimal Care Pathways
Your guide to the best blood cancer treatment
We’ve collaborated with the Cancer Council to create these guides on the best treatment and care options.
Information that might be relevant for your current stage in the journey
-
Your healthcare rights
Learn more about Your healthcare rights and how the Leukaemia Foundation is driving change for Australians with blood cancer.
-
Other side effects
Learn more about Other side effects and how the Leukaemia Foundation is driving change for Australians with blood cancer.
-
Parenting with blood cancer
The challenges of parenting become more complex for a parent who is diagnosed with cancer. Caring for children with the physical…
-
Refractory cancer
Learn more about Refractory cancer and how the Leukaemia Foundation is driving change for Australians with blood cancer.
-
Nutrition and blood cancer
Learn more about Diet and nutrition during treatment and how the Leukaemia Foundation is driving change for Australians with blood…
Other relevant information
-
CarerHealth Care ProfessionalPatientInformationeducation
Useful websites
-
CarerHealth Care ProfessionalPatientHealthcare RightsInformationeducation
Survivorship
-
CarerHealth Care ProfessionalPatientChildhoodEmotional Supporteducation
Children and blood cancer
-
-
-
-
-
-
-
-
-
Blood Cancers A-Z
A
AA secondary amyloidosis
Acute lymphoblastic leukaemia ALL
Acute myeloid leukaemia AML
Acute myelomonocytic leukaemia AMML
Acute promyelocytic leukaemia APML
Afib mutated fibrinogen alpha chain amyloidosis
AL systemic amyloidosis
Amyloidosis
Aplastic anaemia AA
ATTR familial amyloidotic polyneuropathy
ATTR wild type senile amyloidosis
B
Biphenotypic leukaemia
Bisphosphonates myeloma
C
Chronic lymphocytic leukaemia CLL
Chronic myeloid leukaemia CML
H
Hairy cell leukaemia
Hodgkin lymphoma
I
IgA myeloma
IgG myeloma
J
Juvenile myelomonocytic leukaemia JMML
L
Langerhans Cell Histiocytosis LCH
Leukaemia
Light chain myeloma
Lymphocyte depleted HL
Lymphocyte rich HL
Lymphoma
M
MDS with biallelic TP53 inactivation MDS-biTP53
MDS with fibrosis
MDS with hypoplastic MDS-h
MDS with increased blasts MDS-IB1
MDS with increased blasts MDS-IB2
MDS with low blasts MDS-LB
MDS with low blasts and isolated 5q deletion MDS-5q
MDS with low blasts and SF3B1 mutation MDS-SF3B1
Mixed cellularity HL
Monoclonal gammopathy of unknown significance MGUS
MPN Chronic eosinophilic leukaemia CEL
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic neutrophilic leukaemia CNL
MPN Essential thrombocythaemia ET
MPN Polycythaemia Rubra vera PV
MPN Primary myelofibrosis MF
MPN Systemic mastocytosis SM
Multiple myeloma
Myelodysplasia Myelodysplastic neoplasms MDS
Myeloma
Myeloid sarcoma localised leukaemia
Myeloproliferative neoplasms MPN
N
NHL Adult T-Cell leukaemic ATLL
NHL Anaplastic large cell ALCL
NHL Burkitt’s
NHL Cutaneous T-Cell
NHL Diffuse large B-cell DLBCL
NHL Double hit DHL
NHL Follicular
NHL Lymphoplasmacytic Waldenstrom’s macroglobulinaemia WM
NHL MALT
NHL Mantle cell
NHL Marginal zone
NHL Peripheral T-Cell
NHL Primary cutaneous B-cell
NHL Primary mediastinal B-cell PMBCL
NHL Small lymphocytic SLL
NHL Subcutaneous panniculitis-like T-Cell
NHL T-Lymphoblastic
NHL Waldenstroms macroglobulinaemia
Non-Hodgkin lymphoma
Nodular lymphocyte predominant HL
Nodular sclerosing HL
O
Osteosclerotic myeloma
P
Paroxysmal nocturnal haemoglobinuria
Plasmacytoma localised myeloma
POEMS syndrome
R
Richter’s syndrome leukaemia
S
Smouldering indolent myeloma
Solitary plasmacytoma myeloma
Systemic mastocytosis